Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3763121 | 0.87 | — | — | |
| SCHEMBL3754415 | 0.86 | MEN1 (0.33) | MEN1CYP1A2CYP2C9CYP2C19KMT2A | |
| SCHEMBL3753716 | 0.86 | ALOX5AP (0.31) | ALOX5APFEN1 | |
| SCHEMBL3756799 | 0.85 | SMN1; SMN2 (0.35) | MEN1CYP1A2CYP2C9CYP2C19KMT2A | |
| SCHEMBL4555331 | 0.81 | KDM4E (0.35) | MEN1CYP1A2CYP2C9CYP2C19KMT2A | |
| SCHEMBL3757052 | 0.79 | LMNA (0.39) | MEN1CYP1A2CYP2C9CYP2C19KMT2A | |
| SCHEMBL3748475 | 0.77 | ALDH1A1 (0.33) | MEN1CYP1A2CYP2C9CYP2C19KMT2A | |
| SCHEMBL1223224 | 0.74 | — | — | |
| SCHEMBL1222760 | 0.74 | — | — | |
| SCHEMBL1028331 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298141-A1 | SUBSTITUTED PYRIDINE N-OXIDE HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-11-25 | — | — | US | claimed |
| US-20100298141-A1 | SUBSTITUTED PYRIDINE N-OXIDE HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-11-25 | — | — | US | disclosed |
| EP-2120939-A2 | SUBSTITUTED PYRIDINE N-OXIDE HERBICIDES | E. I. Du Pont de Nemours and Company (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008100426-A2 | SUBSTITUTED PYRIDINE N-OXIDE HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298141-A1 | SUBSTITUTED PYRIDINE N-OXIDE HERBICIDES | CYP3A7, CYP2W1, CBR3 | MEN1 3920/4885CYP1A2 36/4885CYP2C9 98/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.